Featured expert
- Kate Marris, PhD candidate in Nutrition at The Ohio State University; Graduate Fellow; cardiac T32 predoctoral trainee.

Researchers in The Ohio State University Department of Food Science and Technology’s Belury Laboratory examine selective metabolic modulators in the diet, studying compounds such as polyunsaturated fatty acids, isoflavones and metabolites derived from dietary constituents.
Recent research completed by Kate Marris, a student of Martha Belury, PhD, RD, professor in the Department of Human Sciences at The Ohio State University, looks into medication for breast cancer. Marris, who is a T32 predoctoral trainee, looks at anthracycline chemotherapy (AC), a cytotoxic antibiotic commonly used to treat breast cancer. While AC increases survival rates for patients, AC also may cause cardiotoxicity that can lead to cardiomyopathy and heart failure.
Marris’ dissertation, titled, “Targeting the Mitochondria to Investigate Anthracycline-induced Cardiotoxicity” examines the molecular mechanisms underlying mitochondrial dysfunction and its role in cardiotoxicity. The overarching goal is to determine if dietary oils exert cardioprotection against AC. Conclusions include:
Future research aims to measure diastolic and mitochondrial function in mouse models of AC cardiotoxicity, in order to improve our understanding of the role of poor mitochondria function in cardiomyopathy caused by AC chemotherapy.